Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 21:30:01 13/05/2024 BST 		5-day change 1st Jan Change
4.03 USD +1.77% Intraday chart for NeuroBo Pharmaceuticals, Inc. +6.05% +9.02%
05-09 NeuroBo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-08 Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target
MT
Ladenburn Thalmann Starts NeuroBo Pharmaceuticals at Buy With $6 Price Target
MT
NEUROBO PHARMACEUTICALS : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. News NeuroBo Pharmaceuticals, Inc.
  5. Analyst Reco.